Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 5 studies | 24% ± 10% | |
hepatocyte | 3 studies | 41% ± 22% |
Insufficient scRNA-seq data for expression of LCAT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 3259.12 | 653 / 653 | 98% | 13.42 | 590 / 605 |
uterus | 100% | 2744.14 | 170 / 170 | 97% | 14.67 | 446 / 459 |
liver | 100% | 7862.78 | 226 / 226 | 97% | 39.41 | 392 / 406 |
esophagus | 97% | 1897.14 | 1408 / 1445 | 97% | 9.60 | 178 / 183 |
prostate | 100% | 3141.13 | 245 / 245 | 90% | 7.27 | 454 / 502 |
adrenal gland | 100% | 1341.19 | 257 / 258 | 90% | 9.43 | 207 / 230 |
kidney | 100% | 1549.00 | 89 / 89 | 89% | 13.44 | 805 / 901 |
bladder | 100% | 2049.38 | 21 / 21 | 87% | 10.82 | 440 / 504 |
pancreas | 92% | 672.31 | 302 / 328 | 94% | 10.67 | 168 / 178 |
brain | 85% | 1064.21 | 2245 / 2642 | 100% | 54.32 | 704 / 705 |
ovary | 99% | 1738.88 | 179 / 180 | 85% | 7.15 | 367 / 430 |
lung | 100% | 2646.94 | 578 / 578 | 84% | 7.34 | 971 / 1155 |
skin | 100% | 1359.26 | 1806 / 1809 | 83% | 6.91 | 393 / 472 |
breast | 100% | 1947.41 | 459 / 459 | 72% | 4.89 | 806 / 1118 |
intestine | 98% | 1747.52 | 949 / 966 | 71% | 4.57 | 372 / 527 |
stomach | 91% | 948.88 | 327 / 359 | 71% | 4.33 | 204 / 286 |
spleen | 100% | 1691.06 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 28.80 | 1 / 1 |
adipose | 100% | 1923.87 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2139.01 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1445.34 | 856 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 7.55 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 94% | 9.46 | 75 / 80 |
tonsil | 0% | 0 | 0 / 0 | 91% | 7.09 | 41 / 45 |
muscle | 72% | 488.02 | 578 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 34% | 170.02 | 319 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042158 | Biological process | lipoprotein biosynthetic process |
GO_0034372 | Biological process | very-low-density lipoprotein particle remodeling |
GO_0006656 | Biological process | phosphatidylcholine biosynthetic process |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0043691 | Biological process | reverse cholesterol transport |
GO_0034375 | Biological process | high-density lipoprotein particle remodeling |
GO_0046470 | Biological process | phosphatidylcholine metabolic process |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0090107 | Biological process | regulation of high-density lipoprotein particle assembly |
GO_0006629 | Biological process | lipid metabolic process |
GO_0030301 | Biological process | cholesterol transport |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0034364 | Cellular component | high-density lipoprotein particle |
GO_0004607 | Molecular function | phosphatidylcholine-sterol O-acyltransferase activity |
GO_0004771 | Molecular function | sterol esterase activity |
GO_0047179 | Molecular function | platelet-activating factor acetyltransferase activity |
GO_0003847 | Molecular function | 1-alkyl-2-acetylglycerophosphocholine esterase activity |
GO_0034186 | Molecular function | apolipoprotein A-I binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LCAT |
Protein name | Phosphatidylcholine-sterol acyltransferase (EC 2.3.1.43) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) Phosphatidylcholine-sterol acyltransferase (EC 2.3.1.43) (1-alkyl-2-acetylglycerophosphocholine esterase) (EC 3.1.1.47) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase) (Platelet-activating factor acetylhydrolase) (PAF acetylhydrolase) Lecithin-cholesterol acyltransferase (EC 2.3.1.43) Lecithin-cholesterol acyltransferase |
Synonyms | |
Description | FUNCTION: Central enzyme in the extracellular metabolism of plasma lipoproteins. Synthesized mainly in the liver and secreted into plasma where it converts cholesterol and phosphatidylcholines (lecithins) to cholesteryl esters and lysophosphatidylcholines on the surface of high and low density lipoproteins (HDLs and LDLs) . The cholesterol ester is then transported back to the liver. Has a preference for plasma 16:0-18:2 or 18:O-18:2 phosphatidylcholines . Also produced in the brain by primary astrocytes, and esterifies free cholesterol on nascent APOE-containing lipoproteins secreted from glia and influences cerebral spinal fluid (CSF) APOE- and APOA1 levels. Together with APOE and the cholesterol transporter ABCA1, plays a key role in the maturation of glial-derived, nascent lipoproteins. Required for remodeling high-density lipoprotein particles into their spherical forms . Catalyzes the hydrolysis of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor or PAF) to 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF) . Also catalyzes the transfer of the acetate group from PAF to 1-hexadecanoyl-sn-glycero-3-phosphocholine forming lyso-PAF . Catalyzes the esterification of (24S)-hydroxycholesterol (24(S)OH-C), also known as cerebrosterol to produce 24(S)OH-C monoesters . . |
Accessions | J3QKT0 ENST00000570980.1 ENST00000570369.5 P04180 I3L0J6 ENST00000576450.1 ENST00000575467.5 I3L215 ENST00000570396.1 J3QSE5 I3L3R0 I3L1Q6 ENST00000573538.5 Q9Y5N3 ENST00000264005.10 |